(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 3.95% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.57%.
Aptargroup's revenue in 2025 is $3,610,693,000.On average, 5 Wall Street analysts forecast ATR's revenue for 2025 to be $243,703,645,850, with the lowest ATR revenue forecast at $242,334,912,125, and the highest ATR revenue forecast at $245,530,117,442. On average, 5 Wall Street analysts forecast ATR's revenue for 2026 to be $257,143,404,099, with the lowest ATR revenue forecast at $255,872,700,591, and the highest ATR revenue forecast at $259,463,847,845.
In 2027, ATR is forecast to generate $270,225,431,114 in revenue, with the lowest revenue forecast at $270,222,137,087 and the highest revenue forecast at $270,228,725,140.